Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK E WEINSTEIN

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1528274040
CMS profile
23441
Location
BELLEVILLE, NJ

General Payments · PY2018–2024

$73,909.68

  • Reported across 563 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$4,714.54

57 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $8,913.00 71
PY2019 $17,754.40 83
PY2020 $6,564.19 80
PY2021 $8,173.42 118
PY2022 $12,889.54 129
PY2023 $14,900.59 25
PY2024 $4,714.54 57

Payment records · PY2024 (57)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $5.33 02/21/2024 Food and Beverage Undisputed 01/23/2026 1106320241 CMS
ABBVIE INC. $1,350.00 03/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1106320243 CMS
ABBVIE INC. $11.60 03/21/2024 Food and Beverage Undisputed 01/23/2026 1106320245 CMS
ABBVIE INC. $18.30 06/07/2024 Food and Beverage Undisputed 01/23/2026 1106320247 CMS
ABBVIE INC. $1,006.25 06/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1106320249 CMS
ABBVIE INC. $15.74 07/01/2024 Food and Beverage Undisputed 01/23/2026 1106320251 CMS
ABBVIE INC. $9.19 07/17/2024 Food and Beverage Undisputed 01/23/2026 1106320253 CMS
ABBVIE INC. $15.17 09/05/2024 Food and Beverage Undisputed 01/23/2026 1106320255 CMS
ABBVIE INC. $1,350.00 10/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1106320257 CMS
ABBVIE INC. $16.96 11/18/2024 Food and Beverage Undisputed 01/23/2026 1106320259 CMS
ABBVIE INC. $17.01 12/14/2024 Food and Beverage Undisputed 01/23/2026 1106320261 CMS
Amgen Inc. $17.00 06/10/2024 Food and Beverage Undisputed 01/23/2026 1111737670 CMS
Amgen Inc. $17.79 10/14/2024 Food and Beverage Undisputed 01/23/2026 1111737672 CMS
Amgen Inc. $17.84 11/11/2024 Food and Beverage Undisputed 01/23/2026 1111737674 CMS
AstraZeneca Pharmaceuticals LP $21.00 06/20/2024 Food and Beverage Undisputed 01/23/2026 1104460276 CMS
AstraZeneca Pharmaceuticals LP $17.68 07/15/2024 Food and Beverage Undisputed 01/23/2026 1105303489 CMS
AstraZeneca Pharmaceuticals LP $18.09 08/01/2024 Food and Beverage Undisputed 01/23/2026 1104776594 CMS
AstraZeneca Pharmaceuticals LP $18.95 08/22/2024 Food and Beverage Undisputed 01/23/2026 1105413766 CMS
AstraZeneca Pharmaceuticals LP $16.88 09/05/2024 Food and Beverage Undisputed 01/23/2026 1105746503 CMS
AstraZeneca Pharmaceuticals LP $13.93 11/18/2024 Food and Beverage Undisputed 01/23/2026 1104271831 CMS
AstraZeneca Pharmaceuticals LP $16.58 12/09/2024 Food and Beverage Undisputed 01/23/2026 1105202395 CMS
AstraZeneca Pharmaceuticals LP $17.06 12/16/2024 Food and Beverage Undisputed 01/23/2026 1105878143 CMS
BioCryst US Sales Co., LLC $18.03 07/22/2024 Food and Beverage Undisputed 01/23/2026 1117474022 CMS
BioCryst US Sales Co., LLC $13.81 11/21/2024 Food and Beverage Undisputed 01/23/2026 1117477682 CMS
CSL Behring $19.41 07/08/2024 Food and Beverage Undisputed 01/23/2026 1134639243 CMS
CSL Behring $23.12 08/06/2024 Food and Beverage Undisputed 01/23/2026 1134639245 CMS
CSL Behring $21.34 10/03/2024 Food and Beverage Undisputed 01/23/2026 1134639247 CMS
CSL Behring $19.60 12/02/2024 Food and Beverage Undisputed 01/23/2026 1134639329 CMS
Cycle Pharmaceuticals Inc $14.09 10/07/2024 Food and Beverage Undisputed 01/23/2026 1154919330 CMS
Genentech USA, Inc. $19.76 09/26/2024 Food and Beverage Undisputed 01/23/2026 1133063421 CMS
Genentech USA, Inc. $17.27 10/24/2024 Food and Beverage Undisputed 01/23/2026 1133063425 CMS
Genentech USA, Inc. $21.49 12/12/2024 Food and Beverage Undisputed 01/23/2026 1133063429 CMS
GENZYME CORPORATION $17.23 09/30/2024 Food and Beverage Undisputed 01/23/2026 1139853785 CMS
GENZYME CORPORATION $17.75 10/17/2024 Food and Beverage Undisputed 01/23/2026 1139853795 CMS
GENZYME CORPORATION $21.50 11/07/2024 Food and Beverage Undisputed 01/23/2026 1139853803 CMS
GlaxoSmithKline, LLC. $15.83 07/26/2024 Food and Beverage Undisputed 01/23/2026 1116586793 CMS
GlaxoSmithKline, LLC. $13.91 09/19/2024 Food and Beverage Undisputed 01/23/2026 1116355565 CMS
GlaxoSmithKline, LLC. $17.21 11/18/2024 Food and Beverage Undisputed 01/23/2026 1116067687 CMS
Incyte Corporation $15.88 09/23/2024 Food and Beverage Undisputed 01/23/2026 1141215288 CMS
kaleo, Inc. $13.13 06/03/2024 Food and Beverage Undisputed 01/23/2026 1126627881 CMS
kaleo, Inc. $17.16 06/13/2024 Food and Beverage Undisputed 01/23/2026 1126627883 CMS
kaleo, Inc. $17.87 09/09/2024 Food and Beverage Undisputed 01/23/2026 1126627885 CMS
LEO Pharma Inc. $15.50 06/24/2024 Food and Beverage Undisputed 01/23/2026 1152655523 CMS
Lilly USA, LLC $20.24 10/28/2024 Food and Beverage Undisputed 01/23/2026 1135178181 CMS
Novartis Pharmaceuticals Corporation $22.80 07/11/2024 Food and Beverage Undisputed 01/23/2026 1087434878 CMS
Novartis Pharmaceuticals Corporation $19.87 08/29/2024 Food and Beverage Undisputed 01/23/2026 1087434890 CMS
Optinose US, Inc. $19.91 10/10/2024 Food and Beverage Undisputed 01/23/2026 1142179298 CMS
PFIZER INC. $17.00 08/19/2024 Food and Beverage Undisputed 01/23/2026 1131840545 CMS
PFIZER INC. $16.47 12/05/2024 Food and Beverage Undisputed 01/23/2026 1131116090 CMS
Pharming Healthcare, Inc. $18.58 10/31/2024 Food and Beverage Undisputed 01/23/2026 1132170761 CMS
Regeneron Healthcare Solutions, Inc. $94.66 05/21/2024 Education Undisputed 01/23/2026 1114249707 CMS
Regeneron Healthcare Solutions, Inc. $17.68 05/30/2024 Food and Beverage Undisputed 01/23/2026 1114249710 CMS
Regeneron Healthcare Solutions, Inc. $18.62 08/26/2024 Food and Beverage Undisputed 01/23/2026 1114249714 CMS
Regeneron Healthcare Solutions, Inc. $16.59 09/16/2024 Food and Beverage Undisputed 01/23/2026 1114249717 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.00 06/17/2024 Food and Beverage Undisputed 01/23/2026 1137696060 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.44 07/29/2024 Food and Beverage Undisputed 01/23/2026 1137696062 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.44 09/12/2024 Food and Beverage Undisputed 01/23/2026 1137696064 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.